Back to the future

CE Mark given for Cepheid’s ‘plus’ COVID and fl u diagnostic test

1

The Xpert Xpress CoV-2/Flu/RSV plus is a rapid diagnostic test for detecting the viruses causing COVID-19, Flu and respiratory syncytial virus (RSV). The plus version provides a third gene target for SARS-CoV-2 detection to deliver broader coverage. The test is designed for use on any of Cepheid’s GeneXpert Systems placed worldwide, with results delivered in approximately 36 minutes. Only one sample is required to run a single, highly sensitive multiplexed test that detects and diff erentiates all four viruses.

2 3 4 5

Shipping to countries accepting CE-marked products began in October.

Henkel launches novel ‘healthcare’ 3D printing resins

Anew class of 3D printing resins for healthcare applications expands Henkel’s Loctite brand. The broad portfolio of high-performance photopolymers off ers a range of biocompatibility standards from safe-to-touch parts to medical devices.

In addition to the established portfolio of Loctite 3D printing resins, the company innovates to deliver tailored formulations to fi t the specifi c application requirements and market demands for optimised production.

Recently, the Henkel 3D printing facilities in Concord (laboratory) and Dixon (production) in California, have achieved the ISO 13485:2016 certifi cation for medical applications. Henkel 3D printing resins are designed and manufactured in accordance with ISO 13485 quality management standards to ensure uniformity in design, development, production, and delivery of medical devices. In Henkel’s case specifi cally, it covers the design and manufacturing of biocompatible resins and other materials used to produce non-implantable medical devices.

Argon Medical launches innovations for portal vein access procedures

Global manufacturer of specialty devices for interventional radiology, vascular surgery, and interventional cardiology Argon Medical Devices has launched two unique portal vein access sets intended for transjugular liver access in diagnostic and interventional procedures.

The SCORPION Portal Vein Access Series addresses the common challenges physicians encounter when placing a transjugular intrahepatic portosystemic shunt or conducting other portal vein access procedures. The series includes Scorpion and ScorpionX, which off er improved visualization, revolutionary navigation control, and enhanced durability to augment existing procedural techniques.

Using a patented curve-incurve system the series off ers physicians 360° range of motion with the needle or stylet used to access the portal vein. Each curved component can work together or independently to accurately steer the device through the liver to the intended target. Existing systems utilize only a single curve limiting the steerability of the needle or stylet. The Scorpion Series’ novel design was created by Dr Lowell

Kahn, a vascular and diagnostic interventional radiologist located in Springfi eld, MA, in conjunction with Hatch Medical.